Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
The Pharmacogenomics Journal
|
April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent
F Aminkeng, C J D Ross, S R Rassekh, et al.
Pediatric Blood & Cancer
|
February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H Visscher, C J D Ross, S R Rassekh, et al.
The Pharmacogenomics Journal
|
May 28, 2014
Pharmacogenomic diversity in Singaporean populations and Europeans
L R Brunham, S L Chan, R Li, et al.
NPJ Precision Oncology
|
July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
A J M Meijer, F A Diepstraten, T Langer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
The Pharmacogenomics Journal
|
April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent
F Aminkeng, C J D Ross, S R Rassekh, et al.
Pediatric Blood & Cancer
|
February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H Visscher, C J D Ross, S R Rassekh, et al.
The Pharmacogenomics Journal
|
May 28, 2014
Pharmacogenomic diversity in Singaporean populations and Europeans
L R Brunham, S L Chan, R Li, et al.
NPJ Precision Oncology
|
July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
A J M Meijer, F A Diepstraten, T Langer, et al.
Page
of 3